Side effects of retinoid therapy on the quality of vision

1. W. H. C. Burgdorf, G. Plewig, H. H. Wolff, M. Landthale and O. Braun-Falco, Braun-Falco’s Dermatology, Springer Verlag, Berlin-Heidelberg 2009.10.1007/978-3-540-29316-3Search in Google Scholar

2. B. Bergler-Czop, Nowy Schemat Terapii Różnych Postaci Trądziku Oparty na Analizie Skórno-Śluzówkowych Objawów Ubocznych Stosowania Retinoidów oraz Stężeń Cytokin Prozapalnych - A New Therapy Scheme of Various Kinds of Acne Based on Skin-mucosal Side-effects of Retinoid Treatment and Pro-inflammatory Cytokines Levels, Ph. D. Thesis, Medical University of Silesia, Publisher Tekst, Katowice 2011.10.3109/15569527.2011.63394922103810Search in Google Scholar

3. E. Papakonstantinou, A. J. Aletras, E. Glass, P. Tsogas, A. Dionyssopoulos, J. Adjaye, S. Fimmel, P. Gouvousis, R. Herwig, H. Lehrach, C. C. Zouboulis and G. Karakiulakis, Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin, J. Invest. Dermatol. 125 (2005) 673-684.10.1111/j.0022-202X.2005.23848.x16185265Search in Google Scholar

4. B. Bergler-Czop and L. Brzezińska-Wcisło, Pro-inflammatory cytokines in patients with various kinds of acne treated with isotretinoin, Postepy Dermatol. Alergol. 31 (2014) 21-28; DOI: 10.5114/ pdia.2014.40655.10.5114/pdia.2014.40655395205124683393Search in Google Scholar

5. L. Beckenbach, J. M. Baron, H. F. Merk, H. Löffler and P. M. Amann, Retinoid treatment of skin diseases, Eur. J. Dermatol. 25 (2015) 384-391; DOI: 10.1684/ejd.2015.2544.10.1684/ejd.2015.254426069148Search in Google Scholar

6. S. C. On and J. Zeichner, Isotretinoin updates, Dermatol. Ther. 26 (2013) 377-389; DOI: 10.1111/dth.12084.10.1111/dth.1208424099068Search in Google Scholar

7. G. Carretero, M. Ribera, I. Belinchón, J. M. Carrascosa, L. Puig, C. Ferrandiz, L. Dehesa, D. Vidal, F. Peral, E. Jorquera, A. González-Quesada, C. Muñoz, J. Notario, F. Vanaclocha and J. C. Moreno, Psoriasis group of the AEDV. Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology, Actas Dermosifiliogr. 104 (2013) 598-616; DOI: 10.1016/j.adengl.2013.01.001.10.1016/j.adengl.2013.01.00123891453Search in Google Scholar

8. U. Cegieła, J. Folwarczna, R. Janiec and W. Janiec, Kompendium Farmakologii, Państwowy Zakład Wydawnictw Lekarskich Publishing, Warsaw 2012, pp. 400-402.Search in Google Scholar

9. K. H. Dragnev, W. J. Petty, S. J. Shah, L. D. Lewis, C. C. Black, V. Memoli, W. C. Nugent, T. Hermann, A. Negro-Vilar, J. R. Rigas and E. Dmitrovsky, A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer, Clin. Cancer Res. 13 (2007) 1794-1800.10.1158/1078-0432.CCR-06-183617363535Search in Google Scholar

10. A. L. Zaenglein, A. L. Pathy, B. J. Schlosser, A. Alikhan, H. E. Baldwin, D. S. Berson, W. P. Bowe, E. M. Graber, J. C. Harper, S. Kang, J. E. Keri, J. J. Leyden, R. V. Reynolds, N. B. Silverberg, L. F. Stein Gold, M. M. Tollefson, J. S. Weiss, N. C. Dolan, A. A. Sagan, M. Stern, K. M. Boyer and R. Bhushan, Guidelines of care for the management of acne vulgaris, J. Am. Acad. Dermatol. (2016) in press; DOI: 10.1016/j.jaad.2015.12.037.10.1016/j.jaad.2015.12.03726897386Search in Google Scholar

11. H. E. Baldwin, M. Nighland, B. Kendall, D. A. Mays, R. Grossman and J. Newburger, 40 years of topical tretinoin use in review, J. Drugs Dermatol. 12 (2013) 638-642.Search in Google Scholar

12. G. Shiva, M. Somaye and J. M. Reza, Improved photostability, reduced skin permeation and irritation of isotretinoin by solid lipid nanoparticles, Acta Pharm. 62 (2012) 547-562; DOI: 10.2478/v10007-012-0032-z.10.2478/v10007-012-0032-z23333889Search in Google Scholar

13. F. T. Fraunfelder, F. W. Fraunfelder and R. Edwards, Ocular side effects possibly associated with isotretinoin usage, Am. J. Ophthalmol. 132 (2001) 299-305; DOI: 10.1016/S0002-9394(01)01024-8.10.1016/S0002-9394(01)01024-8Search in Google Scholar

14. A. Karalezli, M. Borazan, D. D.Altinors, R. Dursun, H. Kiyici and Y. A. Akova, Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin, Cornea 28 (2009) 46-50; DOI: 10.1097/ICO.0b013e318183a396.10.1097/ICO.0b013e318183a39619092405Search in Google Scholar

15. M. J. Ju, J. G. Shin, S. Hoshi, Y. Yasuno, B. H. Lee, S. Tang and T. J. Eom, Three-dimensional volumetric human meibomian gland investigation using polarization-sensitive optical coherence tomography, J. Biomed. Opt. 19 (2014) ID 030503; DOI: 10.1117/1.JBO.19.3.030503.10.1117/1.JBO.19.3.03050324604532Search in Google Scholar

16. R. W. Lambert and R. E. Smith, Pathogenesis of blepharoconjunctivitis complicating 13-cis-retinoic acid (isotretinoin) therapy in a laboratory model, Invest. Ophthalmol. Vis. Sci. 29 (1988) 1559-1564.Search in Google Scholar

17. W. D. Mathers, W. J. Shields, M. S. Sachde, W. M. Petroll and J. V. Jester, Meibomian gland morphology and tear osmolarity: changes with Accutane therapy, Cornea 10 (1991) 286-290.Search in Google Scholar

18. M. Neudorfer, I. Goldshtein, O. Shamai-Lubovitz, G. Chodick, Y. Dadon and V. Shalev, Ocular adverse effects of systemic treatment with isotretinoin, Arch. Dermatol. 148 (2012) 803-808; DOI: 10.1001/archdermatol.2012.352.10.1001/archdermatol.2012.35222508771Search in Google Scholar

19. T. Cumurcu, E. Sezer, R. Kilic and Y. Bulut, Comparison of dose-related ocular side effects during systemic isotretinoin administration, Eur. J. Ophthalmol. 19 (2009) 196-200.10.1177/11206721090190020419253234Search in Google Scholar

20. M. Brelsford and T. C. Beute, Preventing and managing the side effects of isotretinoin, Semin. Cutan. Med. Surg. 27 (2008) 197-206; DOI: 10.1016/j.sder.2008.07.002.10.1016/j.sder.2008.07.00218786498Search in Google Scholar

21. P. A. Sieving, P. Chaudhry, M. Kondo, M. Provenzano, D. Wu, T. J. Carlson, R. A. Bush and D. A. Thompson, Inhibition of the visual cycle in vivo by 13-cis-retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy, Proc. Natl. Acad. Sci. USA 98 (2001) 1835-1840; DOI: 10.1073/pnas.98.4.1835.10.1073/pnas.98.4.18352934311172037Search in Google Scholar

22. S. P. Mollan, M. Woodcock, R. Siddiqi, J. Huntbach, P. Good and R. A. H. Scott, Does use of isotretinoin rule out a career in flying? Br. J. Ophthalmol. 90 (2006) 957-959; DOI: 10.1136/bjo.2006.092833.10.1136/bjo.2006.092833185720916723361Search in Google Scholar

23. J. Santodomingo-Rubido, E. Barrado-Navascués and M. J. Rubido-Crespo, Drug-induced ocular sideeffects with isotretinoin, Ophthalmic Physiol. Opt. 28 (2008) 497-501; DOI: 10.1111/j/1475-1313.2008.00590.x.Search in Google Scholar

24. H. I. Onder, H. Turan, A. C. Kilic, M. Kaya and M. Tunc, Premacular hemorrhage due to isotretinoin use, Cutan. Ocul. Toxicol. 32 (2013) 170-172; DOI: 10.3109/15569527.2012.676121.10.3109/15569527.2012.67612122510043Search in Google Scholar

25. H. Gursoy, I. Cakmak, N. Yildirim and H. Basmak, Presumed isotretinoin-induced, concomitant autoimmune thyroid disease and ocular myasthenia gravis: a case report, Case Rep. Dermatol. 4 (2012) 256-260; DOI: 10.1159/000345680. 10.1159/000345680353195723275770Search in Google Scholar